Ongoing studies into the cognitive deficits and potential treatments of
Alzheimer's Disease are an important part of the clinical research program
of the Behavioral Neurology Unit. We have recently completed a study of
anti-inflammatory medication in Alzheimer's Disease, as well as a study
using a novel MRI approach to diagnosing subtle brain changes associated
with early Alzheimer's Disease. Research using new pharmacologic agents is
anticipated to occur in the near future.